• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

支持性策略以提高多发性硬化症中 IFN β-1b 的依从性——βPlus 观察队列研究的结果。

Supportive strategies to improve adherence to IFN β-1b in multiple sclerosis--results of the βPlus observational cohort study.

机构信息

University Rome, Department of Neurological Sciences, La Sapienza University, S. Andrea Hospital, Multiple Sclerosis Centre, Viale dell'Università 30, 00185 Rome, Italy.

出版信息

J Neurol Sci. 2011 Aug 15;307(1-2):120-6. doi: 10.1016/j.jns.2011.04.026. Epub 2011 Jun 1.

DOI:10.1016/j.jns.2011.04.026
PMID:21636099
Abstract

BACKGROUND

Low adherence to treatment in Multiple Sclerosis (MS) has been shown to lead to poor health outcomes. Various strategies to improve adherence have been suggested including educative programs, injection devices and dedicated nurse assistance.

OBJECTIVE

To assess the impact of elements of the patient support program on adherence; to explore disease factors affecting adherence; and to determine whether these factors influence the choices of supportive elements.

METHODS

A prospective, observational cohort study was conducted. MS patients were eligible if they had switched to Interferon beta-1b (IFNB-1b) between 1 and 3 months prior to inclusion. Data were collected at months 6, 12, 18 and 24 after inclusion. Adherence was defined as completion of both study protocol and medication at 24 months. Patients underwent evaluations of disability, quality of life, depression, and coping styles.

RESULTS

A total of 1077 patients from 15 countries were included, of which 61.8% were adherent to IFNB-1b after 24-months. Depression, quality of life and autoinjector devices were baseline predictors of adherence at 24-months. Coping styles did not show to have substantial impact on adherence. Lower quality of life increased the probability of choosing supportive elements.

CONCLUSION

The study showed that the usage of autoinjector devices chosen during the study was the strongest predictor of drug adherence of all the supportive elements tested in this study.

摘要

背景

多发性硬化症(MS)治疗依从性低已被证明会导致不良健康结局。已经提出了各种提高依从性的策略,包括教育计划、注射装置和专门的护士协助。

目的

评估患者支持计划的各个要素对依从性的影响;探讨影响依从性的疾病因素;并确定这些因素是否影响支持要素的选择。

方法

进行了一项前瞻性、观察性队列研究。符合条件的 MS 患者在纳入前 1 至 3 个月内已转换为干扰素 beta-1b(IFNB-1b)。数据在纳入后第 6、12、18 和 24 个月收集。依从性定义为在 24 个月时完成研究方案和药物治疗。患者接受残疾、生活质量、抑郁和应对方式的评估。

结果

共纳入来自 15 个国家的 1077 名患者,其中 61.8%的患者在 24 个月时对 IFNB-1b 有依从性。抑郁、生活质量和自动注射器设备是 24 个月时依从性的基线预测因素。应对方式对依从性没有显著影响。生活质量较低会增加选择支持要素的概率。

结论

该研究表明,在本研究测试的所有支持要素中,自动注射器设备的使用是药物依从性的最强预测因素。

相似文献

1
Supportive strategies to improve adherence to IFN β-1b in multiple sclerosis--results of the βPlus observational cohort study.支持性策略以提高多发性硬化症中 IFN β-1b 的依从性——βPlus 观察队列研究的结果。
J Neurol Sci. 2011 Aug 15;307(1-2):120-6. doi: 10.1016/j.jns.2011.04.026. Epub 2011 Jun 1.
2
The impact of betaplus program on patient treatment satisfaction with interferon beta-1b in multiple sclerosis: Multicentric cross-sectional survey in the western Balkan countries.β加项目对多发性硬化症患者使用β-1b干扰素治疗满意度的影响:西巴尔干国家多中心横断面调查
Mult Scler Relat Disord. 2017 Jan;11:56-61. doi: 10.1016/j.msard.2016.12.002. Epub 2016 Dec 8.
3
Quality of life and depression in multiple sclerosis patients: longitudinal results of the BetaPlus study.多发性硬化症患者的生活质量和抑郁:BetaPlus 研究的纵向结果。
J Neurol. 2012 Nov;259(11):2319-28. doi: 10.1007/s00415-012-6492-8. Epub 2012 Apr 18.
4
Glatiramer acetate in treatment-naïve and prior interferon-beta-1b-treated multiple sclerosis patients.醋酸格拉替雷在初治和既往接受β-1b干扰素治疗的多发性硬化症患者中的应用
Acta Neurol Scand. 2006 Jun;113(6):378-86. doi: 10.1111/j.1600-0404.2006.00627.x.
5
Persistence and adherence to disease modifying drugs among patients with multiple sclerosis.多发性硬化症患者对疾病修正药物的坚持和依从性。
Curr Med Res Opin. 2010 Mar;26(3):663-74. doi: 10.1185/03007990903554257.
6
Comparison of injection site pain and injection site reactions in relapsing-remitting multiple sclerosis patients treated with interferon beta-1a or 1b.复发缓解型多发性硬化症患者接受β-1a或β-1b干扰素治疗时注射部位疼痛及注射部位反应的比较
Mult Scler. 2007 Nov;13(9):1153-60. doi: 10.1177/1352458507079291.
7
Adherence of adolescents to multiple sclerosis disease-modifying therapy.青少年对多发性硬化症疾病修正疗法的依从性。
Pediatr Neurol. 2009 Aug;41(2):119-23. doi: 10.1016/j.pediatrneurol.2009.03.004.
8
Multiple sclerosis patients treated with intramuscular IFN-β-1a autoinjector in a real-world setting: prospective evaluation of treatment persistence, adherence, quality of life and satisfaction.在真实环境中使用肌肉注射干扰素β-1a自动注射器治疗的多发性硬化症患者:治疗持续性、依从性、生活质量和满意度的前瞻性评估。
Expert Opin Drug Deliv. 2015 Jan;12(1):15-25. doi: 10.1517/17425247.2015.989209. Epub 2014 Nov 28.
9
Tolerability and safety profile of 12- to 28-week treatment with interferon beta-1b 250 and 500 microg QOD in patients with relapsing-remitting multiple sclerosis: a multicenter, randomized, double-blind, parallel-group pilot study.复发缓解型多发性硬化症患者接受干扰素β-1b 250微克和500微克隔日治疗12至28周的耐受性和安全性概况:一项多中心、随机、双盲、平行组试点研究。
Clin Ther. 2008 Jun;30(6):1102-12. doi: 10.1016/j.clinthera.2008.06.013.
10
Multiple sclerosis, interferon beta-1b and depression A prospective investigation.多发性硬化症、干扰素β-1b与抑郁症:一项前瞻性调查
J Neurol. 2002 Jul;249(7):815-20. doi: 10.1007/s00415-002-0725-0.

引用本文的文献

1
Preferences and Perspectives of Specialist Multiple Sclerosis Nurses and Patients with Multiple Sclerosis Regarding the New RebiSmart 3.0 Autoinjector versus Other Assistive Devices.多发性硬化专科护士和多发性硬化患者对新型RebiSmart 3.0自动注射器与其他辅助设备的偏好和看法。
Med Devices (Auckl). 2024 Feb 19;17:59-71. doi: 10.2147/MDER.S438883. eCollection 2024.
2
Factors Associated With Disease-Modifying Therapy Adherence and Persistence in Multiple Sclerosis: A Scoping Literature Review.与多发性硬化症疾病改善治疗依从性和持续性相关的因素:一项范围综述文献。
Int J MS Care. 2023 Sep-Oct;25(5):188-195. doi: 10.7224/1537-2073.2021-139. Epub 2023 Sep 14.
3
The Impact of Patient Support Programs in Europe: A Systematic Literature Review.
《欧洲患者支持计划的影响:系统文献回顾》。
Patient. 2022 Nov;15(6):641-654. doi: 10.1007/s40271-022-00582-y. Epub 2022 Jun 21.
4
Reliability, Satisfaction and Effectiveness of Benralizumab Home Self-Administration in Patients with Severe Eosinophilic Asthma in Real-World Practice: The Auto-Benra Study.倍利珠单抗居家自我给药在重度嗜酸性粒细胞性哮喘患者真实世界实践中的可靠性、满意度及有效性:Auto-Benra研究
J Asthma Allergy. 2022 May 13;15:623-632. doi: 10.2147/JAA.S358738. eCollection 2022.
5
Predictors of Adherence Among Patients With Multiple Sclerosis Using the BETACONNECT Autoinjector: A Prospective Observational Cohort Study.使用BETACONNECT自动注射器的多发性硬化症患者依从性的预测因素:一项前瞻性观察队列研究。
Front Neurol. 2021 Feb 24;12:643126. doi: 10.3389/fneur.2021.643126. eCollection 2021.
6
Adherence to self-administering interferon-β1a using RebiSmart® device in Mexican patients with relapsing multiple sclerosis.墨西哥复发型多发性硬化症患者使用 RebiSmart®装置自我注射干扰素-β1a 的依从性。
PLoS One. 2020 Apr 20;15(4):e0230959. doi: 10.1371/journal.pone.0230959. eCollection 2020.
7
Comparison of the effectiveness of a tailored cognitive behavioural therapy with a supportive listening intervention for depression in those newly diagnosed with multiple sclerosis (the ACTION-MS trial): protocol of an assessor-blinded, active comparator, randomised controlled trial.一项评估者设盲、活性对照、随机对照试验,旨在比较针对新诊断多发性硬化症患者的个体化认知行为疗法与支持性倾听干预对抑郁症的疗效(ACTION-MS 试验):方案。
Trials. 2020 Jan 20;21(1):100. doi: 10.1186/s13063-019-4018-8.
8
Probability discounting of treatment decisions in multiple sclerosis: associations with disease knowledge, neuropsychiatric status, and adherence.多发性硬化症治疗决策的概率折扣:与疾病知识、神经精神状态和依从性的关联。
Psychopharmacology (Berl). 2018 Nov;235(11):3303-3313. doi: 10.1007/s00213-018-5037-y. Epub 2018 Sep 22.
9
Patient Evaluation of Satisfaction and Outcomes with an Autoinjector for Self-Administration of Subcutaneous Belimumab in Patients with Systemic Lupus Erythematosus.患者对用于系统性红斑狼疮患者皮下注射贝利尤单抗的自动注射器的满意度和结局的评价。
Patient. 2018 Feb;11(1):119-129. doi: 10.1007/s40271-017-0276-2.
10
Autoinjector preference among patients with multiple sclerosis: results from a national survey.多发性硬化症患者对自动注射器的偏好:一项全国性调查结果
Patient Prefer Adherence. 2017 Aug 3;11:1325-1334. doi: 10.2147/PPA.S137741. eCollection 2017.